MIB-1 labeling index, Ki-67, is an indicator of invasive intraductal papillary mucinous neoplasm

被引:5
|
作者
Shimura, Tatsuo [1 ]
Kofunato, Yasuhide [2 ]
Okada, Ryo [2 ]
Yashima, Rei [2 ]
Okada, Koji [3 ]
Araki, Kenichiro [3 ]
Hosouchi, Yasuo [4 ]
Kuwano, Hiroyuki [3 ]
Takenoshita, Seiichi [2 ]
机构
[1] Fukushima Med Univ, Dept Canc Biol & Elect, 1 Hikarigaoka, Fukushima 9601295, Japan
[2] Fukushima Med Univ, Dept Organ Regulatory Surg, Fukushima 9601295, Japan
[3] Gunma Univ, Grad Sch Med, Dept Gen Surg Sci, Gunma 3718511, Japan
[4] Gunma Prefecture Saiseikai Maebashi Hosp, Dept Surg & Laparoscop Surg, Maebashi, Gunma 3710821, Japan
关键词
IPMN; MIB-1; Ki-67; invasive IPMN; mural nodule;
D O I
10.3892/mco.2016.908
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Despite strict criteria for the observation of intraductal papillary mucinous neoplasm (IPMN), it remains difficult to distinguish invasive IPMN from non-invasive IPMN. The aim of the present study was to identify an indicator of invasive IPMN. The present study retrospectively evaluated 53 patients (28 with non-invasive and 25 with invasive IPMN) who underwent resection of IPMN, and examined the usefulness of the MIB-1 labeling index as an indicator of invasive IPMN. The MIB-1 labeling indexes in patients with invasive IPMN were significantly higher compared with those with non-invasive IPMN (P<0.001). A receiver operating characteristic curve revealed that the area under the curve was 0.822. These results suggested that a cut-off level for the MIB-1 labeling index should be set to 15.5% to distinguish invasive from non-invasive IPMN. A multivariate analysis using a logistic regression model revealed the MIB-1 labeling index (hazard ratio, 18.692; 95% confidential interval, 4.171-83.760; P<0.001) and the existence of mural nodules (hazard ratio, 6.187, 95% confidential interval, 1.039-36.861; P=0.045) were predictive factors for invasive IPMN. However, no statistically significant differences were observed between patients with a lower MIB-1 labeling index and patients with a higher MIB-1 labeling index (P=0.798). The MIB-1 labeling index must be considered as a candidate for the classification of IPMN.
引用
收藏
页码:317 / 322
页数:6
相关论文
共 50 条
  • [31] Prognostic value of Ki-67 (MIB-1) and p53 in ependymomas
    Sachio Suzuki
    Hidehiro Oka
    Nobuyuki Kawano
    Satoshi Tanaka
    Satoshi Utsuki
    Kiyotaka Fujii
    Brain Tumor Pathology, 2002, 19 (1) : 47 - 47
  • [32] Usefulness of Ki-67 (MIB-1) immunostaining in the diagnosis of pulmonary sclerosing hemangiomas
    Kim, Baek-Hui
    Bae, Yoon-Sung
    Kim, Se Hoon
    Jeong, Hyeong-Jae
    Hong, Soon Won
    Yoon, Sun Och
    APMIS, 2013, 121 (02) : 105 - 110
  • [33] PROLIFERATION MARKERS MIB-1 (KI-67) AND PCNA IN PULMONARY NEUROENDOCRINE TUMORS
    DURHAM, JR
    NAKHLEH, RE
    SWANSON, PE
    FISCHER, JR
    ZARBO, RJ
    LABORATORY INVESTIGATION, 1994, 70 (01) : A150 - A150
  • [34] Prognostic Significance of Ki-67 Labeling Index in Papillary Thyroid Carcinoma
    Ito, Yasuhiro
    Miyauchi, Akira
    Kakudo, Kennichi
    Hirokawa, Mitsuyoshi
    Kobayashi, Kaoru
    Miya, Akihiro
    WORLD JOURNAL OF SURGERY, 2010, 34 (12) : 3015 - 3021
  • [35] MIB-1 (Ki-67) immunostaining of breast cancer cells in cytologic smears
    Dalquen, P
    Baschiera, B
    Chaffard, R
    Dieterich, H
    Feichter, GE
    Kramer, K
    Torhorst, J
    ACTA CYTOLOGICA, 1997, 41 (02) : 229 - 237
  • [36] Prognostic Significance of Ki-67 Labeling Index in Papillary Thyroid Carcinoma
    Yasuhiro Ito
    Akira Miyauchi
    Kennichi Kakudo
    Mitsuyoshi Hirokawa
    Kaoru Kobayashi
    Akihiro Miya
    World Journal of Surgery, 2010, 34 : 3015 - 3021
  • [37] Prognostic significance of Ki-67 labeling indices obtained using MIB-1 monoclonal antibody in patients with supratentorial astrocytomas
    Wakimoto, H
    Aoyagi, M
    Nakayama, T
    Nagashima, G
    Yamamoto, S
    Tamaki, M
    Hirakawa, K
    CANCER, 1996, 77 (02) : 373 - 380
  • [38] PROLIFERATIVE POTENTIAL OF SPORADIC AND NEUROFIBROMATOSIS 2-ASSOCIATED SCHWANNOMAS AS STUDIED BY MIB-1 (KI-67) AND PCNA LABELING
    ANTINHEIMO, J
    HAAPASALO, H
    SEPPALA, M
    SAINIO, M
    CARPEN, O
    JAASKELAINEN, J
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1995, 54 (06): : 776 - 782
  • [39] Prognostic value of Ki-67 (MIB-1) and p53 in ependymomas.
    Suzuki S.
    Oka H.
    Kawano N.
    Tanaka S.
    Utsuki S.
    Fujii K.
    Brain Tumor Pathology, 2001, 18 (2) : 151 - 154
  • [40] Growth fraction determination in pulmonary hypoplasia using Ki-67 (MIB-1) antibody
    Thomas, PA
    Durbin, J
    Langston, C
    Raab, SS
    Jagirdar, J
    Greco, MA
    PEDIATRIC PATHOLOGY & LABORATORY MEDICINE, 1996, 16 (05): : 745 - 753